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imick Arrhythmogenic Right
entricular Cardiomyopathy
henotype by Electroanatomic
apping?
e read with interest the study of Pieroni et al. (1). Although
e fully agree on the superiority of endomyocardial biopsy
EMB) for a specific diagnosis of the underlying disease,
specially considering that fibro-fatty replacement and low
lectrical voltage also may occur in the setting of sarcoid
ardiomyopathy (2), we have some concerns with regard to their
ndings.
The authors report that 50% of patients with the clinical
iagnosis of arrhythmogenic right ventricular cardiomyopathy
ARVC) had “active myocarditis.” This means that an ARVC
henotype (inverted T-wave in right pre-cordial leads, ventricular
achycardia of left bundle branch block morphology, morpholog-
cal abnormalities of the right ventricle at echocardiography/
ngiography/magnetic resonance imaging [MRI], late potentials,
2,000 premature ventricular beats at Holter monitoring) fre-
uently corresponds to myocarditis with predominant involvement
f the right ventricle. In our longstanding experience with EMB,
his is a rare occurrence. Additionally, 30 patients with an ARVC
henotype collected in 1 year seem unrealistic for a single center.
An inflammatory infiltrate of 7 lymphocytes/mm2 is too scanty
o be considered diagnostic for active myocarditis. This number is
ithin the normal limits. In all the published literature on voltage
apping, none have previously reported a positive voltage map
ith “active myocarditis” (3,4). Only a phenomenon of scarring
ssociated with myocarditis may account for such a loss of
yocardium to generate low electrical voltage, and this may occur
n the setting of chronic (nonacute) myocarditis.
Although it has not been documented, MRI did not show
ignificant differences between patients with “active myocarditis” and
RVC in terms of delayed enhancement, which was high both in the
ight and in the left ventricular walls, a finding again suggestive of
xtensive replacement-type fibrosis in both subgroups. Surprisingly,
he authors did not find any evidence of fibrosis at EMB in any
atient with “active myocarditis,” positive electroanatomic mapping,
nd delayed enhancement at MRI.
It is noteworthy that the patient in Figure 2 of Pieroni et al. (1),
ith positive electroanatomic mapping and a histological diagnosis
f active myocarditis, shows a clear-cut picture at angiography of
pile d’assiettes,” which is almost pathognomonic of ARVC (5).
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eply
e appreciate the interest of Dr. Thiene and colleagues in our
ork (1). However, despite their longstanding experience in this
eld, some of their comments could cause a misleading interpre-
ation of our findings.
In particular, their concern regarding the prevalence of right
entricular myocarditis among patients with a diagnosis of nonin-
asive arrhythmogenic right ventricular cardiomyopathy (ARVC)
s surprising when considering that in a recent study (2) they
iagnosed an active myocarditis in 40% of patients with a clinical
iagnosis of ARVC (10 of 25 patients with a definite histological
iagnosis). As well as Padua University, our institution is a referral
enter for arrhythmias and cardiomyopathies, and a significant
roportion of the patients enrolled in 1 year were referred for
urther invasive studies from southern Italian hospitals after
oninvasive evaluation suggested a diagnosis of ARVC.
With regard to histological evaluation, we clearly stated that the
iagnosis of active myocarditis was based on Dallas criteria but also
equired the demonstration of a significant number of activated
nd cytotoxic T lymphocytes. An amount of 7 lymphocytes/
m2, even if identified as activated/cytotoxic, can be still consid-
red arbitrary, as it is the case for other criteria adopted by other
roups (3). Moreover, confusion should be avoided between the
erms “active” and “acute” representing, respectively, a histological
nd clinical definition. It is evident from the text and tables that all
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September 22, 2009:1190–4f our patients were affected by a chronic active myocarditis, a
ell-established clinico-pathologic entity characterized by ongoing
yocardial inflammation and necrosis with different degrees of
eplacement fibrosis in patients with chronic symptoms (in this
ase, ventricular arrhythmias). Although not detailed in this study,
e previously reported that patients with chronic active myocar-
itis mimicking ARVC present, at histomorphometric analysis,
alues of fibrosis comparable to patients with a histological
iagnosis of ARVC (4). Accordingly, as clearly documented in
able 2 of the present study (1), we failed to observe any difference
n terms of delayed enhancement between the 2 groups. Never-
heless, we think that fibrosis should not be considered the unique
istological substrate of low-voltage areas, grossly defined by
lectrophysiologists as “scar.” We learned from cardiac magnetic
esonance how delayed enhancement, initially considered synony-
ous with fibrosis, could indeed result from any cause of intersti-
ial expansion including edema, necrosis, inflammation, or amyloid
eposition. Similarly, inflammation might modulate electrical
roperties of myocardium inducing a low-voltage area before
eplacement fibrosis occurs. The adoption of the simplistic equa-
ion: low-voltage  fibrosis, may retard the comprehension of
rrhythmogenesis in myocardial disorders.
Our study demonstrates that current diagnostic criteria should be
evisited and suggests that further studies including both electroana-
omic mapping-guided endomyocardial biopsy and genetic analysis of
atients with familial and sporadic forms of ARVC will allow
larification of the complex link between desmosomal abnormalities,
nflammation, and fibrofatty replacement.
It is noteworthy that the angiographic picture of “pile
’assiettes” [pile of dishes] in a patient with myocarditis was
hosen to emphasize the possible overlap of angiographic findings
etween ARVC and myocarditis.
Maurizio Pieroni, MD, PhD
rancesca Marzo, MD
ulvio Bellocci, MD
ilippo Crea, MD
Cardiology Department
atholic University
argo A. Gemelli 8
0168 Rome
taly
-mail: mauriziopieroni@yahoo.com
doi:10.1016/j.jacc.2009.05.054
EFERENCES
. Pieroni M, Dello Russo A, Marzo F, et al. High prevalence of
myocarditis mimicking arrhythmogenic right ventricular cardiomyopa-
thy: differential diagnosis by electroanatomic mapping-guided biopsy.
J Am Coll Cardiol 2009;53:681–9.
. Corrado D, Basso C, Leoni L, et al. Three-dimensional electroana-
tomic voltage mapping increases accuracy of diagnosing arrhythmogenic
right ventricular cardiomyopathy/dysplasia. Circulation 2005;111:
3042–50.
. Caforio AL, Calabrese F, Angelini A, et al. A prospective study of
biopsy-proven myocarditis: prognostic relevance of clinical and aetio-
pathogenetic features at diagnosis. Eur Heart J 2007;28:1326–33.
. Chimenti C, Pieroni M, Maseri A, Frustaci A. Histologic findings
in patients with clinical and instrumental diagnosis of sporadic
arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol
2004;43:2305–13.ulmonary Hypertension in
eart Failure With Preserved
jection Fraction
ny Pathophysiological Role of
itral Regurgitation
read with interest the study by Lam et al. (1) as an important
ontribution to the pathophysiological and clinical impact of
ulmonary hypertension (PH) in hypertensive patients with
eart failure and preserved left ventricular ejection fraction
HFpEF). Recent guidelines on arterial PH recognize HFpEF
s a growing cause of left-sided PH (2), but a definitive
ppreciation of its true prevalence and prognostic relevance is
acking. The present study provides some new important
nformation on this subject.
It is noteworthy that HFpEF was associated, in a high rate of
ases (83%), with a typical hemodynamic pattern of pre-
apillary PH, and a strong correlation was found between
ulmonary artery systolic pressure and pulmonary capillary
edge pressure. Most important, pulmonary artery systolic
ressure, rather than other echocardiography-derived measures
f diastolic dysfunction, was the only significant multivariate
redictor of mortality, a finding that was confirmed even when
ombined comorbid diseases potentially contributing to PH
evelopment, such as chronic obstructive pulmonary disease,
ere taken into account.
In patients with systolic heart failure, a major determinant of
H development is mitral regurgitation (3,4). Whether mitral
egurgitation could be a putative factor in the pathogenesis of
H in HFpEF patients remains an open and intriguing ques-
ion. Accordingly, it would be of interest if the authors could
rovide some details on how many HFpEF patients exhibited
itral regurgitation, especially in comparison with control
ypertensive patients without HFpEF. Definitive appreciation
f the relative pathophysiological role of mitral insufficiency in
he PH development and severity may predictably represent a
tep forward in the progressive fascinating characterization of
FpEF patients.
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